The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PERSIAN trial: Early results from a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer.
 
Giulio Francolini
No Relationships to Disclose
 
Vanessa Di Cataldo
No Relationships to Disclose
 
Pietro Garlatti
No Relationships to Disclose
 
Saverio Caini
No Relationships to Disclose
 
Alessio Bruni
No Relationships to Disclose
 
Nicola Simoni
No Relationships to Disclose
 
Matteo Augugliaro
No Relationships to Disclose
 
Roberto Iacovelli
Honoraria - Astellas Pharma; IPSEN; MSD; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Eisai; Genenta Science; Janssen; Merck; MSD; Novartis; Pfizer; Sanofi
Speakers' Bureau - Ipsen; Janssen; MSD; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; MSD; Pfizer
 
Luca Tagliaferri
No Relationships to Disclose
 
Nicola Battelli
No Relationships to Disclose
 
Gianluca Ingrosso
No Relationships to Disclose
 
Angelo Porreca
No Relationships to Disclose
 
Marco Trovò
No Relationships to Disclose
 
Giuseppe Fornarini
No Relationships to Disclose
 
Giuseppe Iorio
No Relationships to Disclose
 
Alessia Guarneri
No Relationships to Disclose
 
Michele Sisani
No Relationships to Disclose
 
Lorenzo Antonuzzo
No Relationships to Disclose
 
Alfio Di Grazia
No Relationships to Disclose
 
Lorenzo Livi
No Relationships to Disclose
 
PERSIAN working group
No Relationships to Disclose